References
Fahrleitner A, Dobnig H, Obernosterer A, et al. Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease. J Gen Intern Med. 2002;17:663–9.
Holick MF, Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes. 2002;9:87–98.
Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet. 1998;351:805–6.
Glerup H, Mikkelsen K, Poulsen L, et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med. 2000;66:419–24.
Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2000;22:477–501.
Harris SS, Soteriades E, Stina Coolidge JA, et al. Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. J Clin Endocrinol Metab. 2001;85:4125–30.
Gloth FM, Tobin JD, Sherman SS, Hollis BW. Is the recommended daily allowance for vitamin D too low for the homebound elderly? J Am Geriatr Soc. 1991;39:137–41.
Chapuy MC, Preziosi P, Maaner M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997;7: 439–43.
Nesby-O’Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr. 2002;76:187–92.
Tangpricha V, Pearce EN, Chen TC, Holick MF. Vitamin D insufficiency among free-living adults. Am J Med. 2002;112:659–62.
Institute of Medicine. Dietary Reference Intakes for Calcium Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington DC: National Academy Press, 1997.
Harris SS, Dawson-Hughes B, Perrone GA. Plasma 25-hydroxy-vitamin D responses of younger and older men to three weeks of supplementation with 1800 IU/day of vitamin D. J Am Coll Nutr. 1999;18:470–4.
Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69:842–56.
Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension. 1997;30:150–6.
Hypponen E, Laara E, Reunanaen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001;358:1500–3.
Luscombe CJ, Freyer AA, French ME, et al. Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet. 2001;358:641–2.
Grant WB. An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer. 2002;94:272–81.
Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: eight year prospective study. Lancet. 1989;2:1176–8.
Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Cancer. 1992;70:2861–9.
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229–38.
Weishaar RE, Simpson RU. The involvement of the endocrine system in regulating cardiovascular function: Emphasis on vitamin D3. Endocr Rev. 1989;10:1–15.
Maeda S, Sutliff RL, Qian J, et al. Targeted overexpression of parathyroid hormone-related protein (PTHrP) to vascular smooth muscle in transgenic mice lowers blood pressure and alters vascular contractility. Endocrinology. 1999;140:1815–25.
Author information
Authors and Affiliations
Additional information
This work was supported in party by NIH grant MO1R00533.
Rights and permissions
About this article
Cite this article
Holick, M.F. Sunlight and vitamin D. J GEN INTERN MED 17, 733–735 (2002). https://doi.org/10.1046/j.1525-1497.2002.20731.x
Issue Date:
DOI: https://doi.org/10.1046/j.1525-1497.2002.20731.x